140 related articles for article (PubMed ID: 10844276)
1. [Pharmaceutical contribution to the non specific challenge in bronchial provocation tests].
Bonte F; Berneron C; Torck M; Toguyeni E; Mornay E
Ann Pharm Fr; 2000 May; 58(3):165-9. PubMed ID: 10844276
[TBL] [Abstract][Full Text] [Related]
2. Methacholine dry powder inhaler as a new tool for bronchial challenge test.
Colombo G; Terzano C; Colombo P; Petroianni A; Ricci A; Buttini F
Int J Pharm; 2008 Mar; 352(1-2):165-71. PubMed ID: 18055141
[TBL] [Abstract][Full Text] [Related]
3. Validation of a single concentration methacholine inhalation provocation test (SCIPT) in children.
Hagmolen of ten Have W; van den Berg NJ; van der Palen J; Bindels PJ; van Aalderen WM
J Asthma; 2005; 42(6):419-23. PubMed ID: 16293536
[TBL] [Abstract][Full Text] [Related]
4. The pharmacology of aerosolized airway challenge.
Wagers SS; Irvin CG
Respir Care Clin N Am; 1999 Dec; 5(4):633-48. PubMed ID: 10565885
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.
Crapo RO; Casaburi R; Coates AL; Enright PL; Hankinson JL; Irvin CG; MacIntyre NR; McKay RT; Wanger JS; Anderson SD; Cockcroft DW; Fish JE; Sterk PJ
Am J Respir Crit Care Med; 2000 Jan; 161(1):309-29. PubMed ID: 10619836
[No Abstract] [Full Text] [Related]
6. Deep inhalation bronchoprotection.
Cockcroft DW; Davis BE
Ann Allergy Asthma Immunol; 2012 Jul; 109(1):74-5. PubMed ID: 22727163
[No Abstract] [Full Text] [Related]
7. Methacholine inhalation challenge in patients with chronic cough induced by angiotensin-converting enzyme inhibitors.
Wongtim S; Chareonlap P; Mogmued S
J Med Assoc Thai; 1996 Mar; 79(3):166-70. PubMed ID: 8708498
[TBL] [Abstract][Full Text] [Related]
8. Dose vs concentration in methacholine challenge.
Donado CD
Ann Allergy Asthma Immunol; 2007 Jun; 98(6):598. PubMed ID: 17601278
[No Abstract] [Full Text] [Related]
9. Induction and recovery phases of methacholine-induced bronchoconstriction using FEV1 according to the degree of bronchial hyperresponsiveness.
Mannino F; Sposato B; Ricci A; Grasso D; De Clementi F; Mariotta S
Lung; 2001; 179(3):137-45. PubMed ID: 11891604
[TBL] [Abstract][Full Text] [Related]
10. Standardization of methacholine inhalation challenge.
Sekerel BE; Saraçlar Y; Tuncer A; Adalioğlu G; Cetinkaya F
Turk J Pediatr; 1997; 39(2):165-72. PubMed ID: 9223913
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of sensitivity and specifity of two bronchial provocation tests with methacholine and hypertonic saline in bronchial hyperreactivity evaluation in asthmatics].
Piotrowska T; Siergiejko G; Siergiejko Z
Pol Merkur Lekarski; 2007 Feb; 22(128):126-9. PubMed ID: 17598657
[TBL] [Abstract][Full Text] [Related]
12. Safety of methacholine challenges in a multicenter pediatric asthma study.
Covar RA; Colvin R; Shapiro G; Strunk R
J Allergy Clin Immunol; 2006 Mar; 117(3):709-11. PubMed ID: 16522478
[No Abstract] [Full Text] [Related]
13. Bronchial responsiveness to methacholine and adenosine 5'-monophosphate in atopic and non-atopic preschool children with recurrent wheezing.
Kim DK; Choi SH; Yu J; Yoo Y; Koh YY
Clin Exp Allergy; 2007 Jan; 37(1):15-21. PubMed ID: 17210037
[TBL] [Abstract][Full Text] [Related]
14. [Pharmacologic substances for bronchial provocation testing].
Ferlinz R
Internist (Berl); 1997 Aug; 38(8):778-9. PubMed ID: 9378625
[No Abstract] [Full Text] [Related]
15. Endobronchial injection of botulinum toxin for the reduction of bronchial hyperreactivity induced by methacholine inhalation in dogs.
Al-Halfawy A; Gomaa NE; Refaat A; Wissa M; Wahidi MM
J Bronchology Interv Pulmonol; 2012 Oct; 19(4):277-83. PubMed ID: 23207526
[TBL] [Abstract][Full Text] [Related]
16. Interpretation of the "positive" methacholine challenge.
Hewitt DJ
Am J Ind Med; 2008 Oct; 51(10):769-81. PubMed ID: 18702111
[TBL] [Abstract][Full Text] [Related]
17. [Randomized double-blind study (third place blinded) to examine the effectiveness and side effects of methacholine in the nonspecific bronchial provocation test].
Huber H; Lauschner R; Papenfuss F; Allmers H; Baur X
Pneumologie; 2000 Mar; 54(3):99-103. PubMed ID: 10783648
[TBL] [Abstract][Full Text] [Related]
18. Nebulizer output for methacholine challenges with the KoKo Digidoser.
Khan YR; McDonough P; Cockcroft DW; David BE; Hendeles L
J Allergy Clin Immunol; 2005 Oct; 116(4):924-6. PubMed ID: 16210072
[No Abstract] [Full Text] [Related]
19. Airway responsiveness to methacholine and deep inhalations in subjects with rhinitis without asthma.
Crimi E; Saporiti R; Bartolini S; Baroffio M; Pellegrino R; Brusasco V
J Allergy Clin Immunol; 2008 Feb; 121(2):403-7. PubMed ID: 17980415
[TBL] [Abstract][Full Text] [Related]
20. Airway hyperreactivity detected by methacholine challenge in children with sickle cell disease.
Ozbek OY; Malbora B; Sen N; Yazici AC; Ozyurek E; Ozbek N
Pediatr Pulmonol; 2007 Dec; 42(12):1187-92. PubMed ID: 17960821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
